Last update:
Oncology news
Pre-surgery immunotherapy may improve treatment for deadly brain cancer
With a five-year survival rate of barely 5%, glioblastoma remains one of the deadliest brain cancers. First-line treatment consists of surgery to remove as much tumor tissue as possible.
1 hour ago
0
0
Healthier fats linked to longer survival after prostate cancer diagnosis
Men diagnosed with nonmetastatic prostate cancer can generally expect to live for many years after their diagnosis. However, cardiovascular disease and other cancers remain important threats to their long-term health. For ...
2 hours ago
0
0
Largest study supports three courses of radiation for children with deadly brain tumor
Children with one of the deadliest forms of brain cancer may benefit from an additional course of radiation therapy after their disease returns, according to new research from the Icahn School of Medicine at Mount Sinai. ...
1 hour ago
0
0
Urine test identifies more than nine in ten bladder cancers, clinical study finds
New research has found that more than 9 in 10 patients with bladder cancer were identified through a noninvasive urine test after urgent referral. The study, led by the University of Birmingham and Nonacus Ltd., involved ...
3 hours ago
0
0
Large language model-based system identifies cardiac event data in cancer patients' electronic health records
Patients with breast and lung cancer are at increased risk of cardiotoxicity, or heart-related damage caused by cancer treatments, because of the proximity of the heart, lungs and breasts. Cardiotoxicity increases the risk ...
6 hours ago
0
1
First human clinical trial to test precision form of FLASH proton therapy
A new form of proton therapy—designed to deliver cancer-killing radiation therapy in less than a second, through fewer sessions, with potentially less risk of damaging side effects—is now being tested in a phase 1 clinical ...
4 hours ago
0
1
How melanoma silences the skin's natural antitumor defense
Cancers actively remodel their surrounding cells and tissues to create a microenvironment that favors their growth, survival and spread. Melanoma, a cancer of the pigment-producing melanocytes of the skin, is one of the most ...
22 hours ago
0
5
Low-dose THC keeps breast cancer cells in tumor models from reverting to an aggressive state
Recent discoveries have revealed that breast cancer cells are more flexible than previously thought. Some can change from a differentiated state, when a mature cell has taken on a specific function, back to a more stem-like ...
Q&A: Combining diagnosis, staging, tumor localization and surgery into a minimally invasive procedure for lung cancer
For patients with early-stage lung cancer, the journey from diagnosis to treatment often involves multiple procedures spread across several weeks or even months. During that time, patients may undergo separate biopsies to ...
16 hours ago
0
2
How does the cancer drug Keytruda work? And how is it different from chemo?
From today, the Australian government will expand Pharmaceutical Benefits Scheme (PBS) access to the drug Keytruda for three additional types of cancer.
19 hours ago
0
5
Cancer cachexia: How a tumor protein drives wasting in the body
Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM) have identified a previously unknown ...
18 hours ago
0
3
Creating new 3D models to test drugs in pediatric sarcoma: A postdoc's recipe for research
The Great British Bake Off offers drama, baking tips and—for one viewer in South Carolina—inspiration for creating 3D models that can be used to test cancer drugs.
17 hours ago
0
4
Supplement plus chemotherapy boosts pancreatic cancer survival
When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences ...
Sep 1, 2026
0
134
Stress and depression, not heart damage, may drive long-term breast cancer fatigue
For breast cancer survivors, new research shows that feelings of depression and perceptions of psychological stress make the biggest difference in whether they experience fatigue up to two years after chemotherapy started.
Sep 1, 2026
0
9
Protein buildup may shape cancer drug response
The way cancer-causing proteins accumulate in tumors may influence how effectively a promising new generation of medicines can remove them, a study suggests. Researchers found that PROTAC (Proteolysis Targeting Chimeras) ...
Sep 1, 2026
0
4
Major study reveals key differences in bowel cancer before and after age 50
One of Australia's largest real-world studies of younger adults with advanced bowel cancer has identified important differences between cancers diagnosed before and after age 50, which could help doctors tailor treatments ...
Sep 1, 2026
0
4
Investment in blood cancer research has saved nearly 26 million years of life, but disparities remain
Over the past 75 years, advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States, according to results of an analysis led by researchers at Blood Cancer United and ...
Sep 1, 2026
0
3
Scientists in France pinpoint why STING pathway hasn't been harnessed for cancer therapy yet
Deep within the cellular landscape, a quiet failure was taking place, impeding a potentially successful form of cancer treatment. For years, scientists hoped an essential part of the innate immune system that detects foreign ...
T cell therapy shows promise in treating aggressive brain cancer
A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T (CAR-T) cell therapy is a form ...
Aug 31, 2026
0
40
Tumor 'floor plans' may predict immunotherapy response better than current biomarkers
Spatial transcriptomics is a powerful tool for creating a detailed map of not just how genes are expressed in a piece of tissue, but also where genetic activity takes place in different cells and locations within the tissue. ...
Aug 31, 2026
0
6
A 'one-two punch' against aggressive breast cancer could offer an alternative to chemotherapy
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease ...
Aug 31, 2026
0
9
Cancer's malignant remote control: How tumors reprogram liver fat metabolism to disarm immune cells
In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the genetic aberrations and microenvironmental peculiarities of tumors and their constituent cells. Such ...
Aug 31, 2026
0
7
An RNA molecule contributes to therapy resistance of triple negative breast cancer
Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer. Chemotherapy before or after surgery remains the standard treatment regimen for stage I–III TNBC. Only a small portion of patients can benefit ...
Aug 31, 2026
0
4
Cardiologist referrals improve cholesterol levels in prostate cancer patients, but may not be necessary for all
Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A large international, first-of-its-kind study led by Hamilton researchers found that routine referrals to an internist ...
Aug 30, 2026
0
389
Breast cancer survivors could avoid lifelong heart medication, research suggests
Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers, and most won't need to continue treatment long term, according ...
Aug 30, 2026
0
27
